Literature DB >> 12151536

Rho signaling pathway targeted to promote spinal cord repair.

Pauline Dergham1, Benjamin Ellezam, Charles Essagian, Hovsep Avedissian, William D Lubell, Lisa McKerracher.   

Abstract

The Rho signaling pathway regulates the cytoskeleton and motility and plays an important role in neuronal growth inhibition. Here we demonstrate that inactivation of Rho or its downstream target Rho-associated kinase (ROK) stimulated neurite growth in primary cells of cortical neurons plated on myelin or chondroitin sulfate proteoglycan substrates. Furthermore, treatment either with C3 transferase (C3) to inactivate Rho or with Y27632 to inhibit ROK was sufficient to stimulate axon regeneration and recovery of hindlimb function after spinal cord injury (SCI) in adult mice. Injured mice were treated with a single injection of Rho or Rho-associated kinase inhibitors delivered in a protein adhesive at the lesion site. Treated animals showed long-distance regeneration of anterogradely labeled corticospinal axons and increased levels of GAP-43 mRNA in the motor cortex. Behaviorally, inactivation of Rho pathway induced rapid recovery of locomotion and progressive recuperation of forelimb-hindlimb coordination. These findings provide evidence that the Rho signaling pathway is a potential target for therapeutic interventions after spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151536      PMCID: PMC6758168          DOI: 20026637

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  201 in total

1.  Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.

Authors:  Jee Y Lee; So R Kang; Tae Y Yune
Journal:  J Neurotrauma       Date:  2015-03-06       Impact factor: 5.269

2.  Recovery from chronic spinal cord contusion after Nogo receptor intervention.

Authors:  Xingxing Wang; Philip Duffy; Aaron W McGee; Omar Hasan; Grahame Gould; Nathan Tu; Noam Y Harel; Yiyun Huang; Richard E Carson; David Weinzimmer; Jim Ropchan; Larry I Benowitz; William B J Cafferty; Stephen M Strittmatter
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

3.  Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury.

Authors:  Farida Hellal; Andres Hurtado; Jörg Ruschel; Kevin C Flynn; Claudia J Laskowski; Martina Umlauf; Lukas C Kapitein; Dinara Strikis; Vance Lemmon; John Bixby; Casper C Hoogenraad; Frank Bradke
Journal:  Science       Date:  2011-01-27       Impact factor: 47.728

4.  The developmental loss of the ability of Purkinje cells to regenerate their axons occurs in the absence of myelin: an in vitro model to prevent myelination.

Authors:  Lamia Bouslama-Oueghlani; Rosine Wehrlé; Constantino Sotelo; Isabelle Dusart
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

5.  Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation.

Authors:  Dietmar Fischer; Victoria Petkova; Solon Thanos; Larry I Benowitz
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

6.  Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system.

Authors:  Ping Yang; Hui-zhong Wen; Jin-hai Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-12       Impact factor: 6.150

Review 7.  Spinal cord injury: a systematic review of current treatment options.

Authors:  David W Cadotte; Michael G Fehlings
Journal:  Clin Orthop Relat Res       Date:  2011-03       Impact factor: 4.176

8.  Large-scale in vivo femtosecond laser neurosurgery screen reveals small-molecule enhancer of regeneration.

Authors:  Chrysanthi Samara; Christopher B Rohde; Cody L Gilleland; Stephanie Norton; Stephen J Haggarty; Mehmet Fatih Yanik
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

9.  RhoA inactivation prevents photoreceptor axon retraction in an in vitro model of acute retinal detachment.

Authors:  Aurora Maria Fontainhas; Ellen Townes-Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

10.  Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia.

Authors:  Akira Hirata; Masaru Inatani; Yasuya Inomata; Naoko Yonemura; Takahiro Kawaji; Megumi Honjo; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-31       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.